NCT01321437 2021-01-20
Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma
University of California, Irvine
Phase 2 Completed
Clinical Trials
4 trialsNCT01174238 2018-06-08
A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma
University of California, San Francisco
Phase 2 Completed
NCT01533948 2018-05-09
Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery
Roswell Park Cancer Institute
Phase 2 Terminated
NCT00094107 2012-06-26
Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma
Pfizer
Phase 2 Completed